| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CEO
3 companies
Mullen James C is a CEO at Editas Medicine, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 2 sells.
Estimated insider holdings value: $2.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | EDIT Editas Medicine, Inc. | CEO | Sell | 18,252 | $26.95 | $491,979.01 | -19.4% | -22.7% | -69.5% | |
| Oct 18, 2021 | EDIT Editas Medicine, Inc. | CEO | Sell | 13,805 | $38.03 | $525,033.14 | -19.3% | -47.9% | -67.5% | |
| Mar 2, 2021 | EDIT Editas Medicine, Inc. | CEO | Buy | 25,000 | $46.27 | $1,156,800.00 | +250.0% | - | - | |
| May 18, 2018 | EDIT Editas Medicine, Inc. | Director | Buy | 10,000 | $38.03 | $380,252.00 | New | - | - | |
| Nov 13, 2017 | PODD Insulet Corp | Director | Buy | 2,500 | $67.45 | $168,632.75 | +80.7% | - | - |